Immunoassay Analyzer
Poclight The 5th Generation Of Homogeneous CLIA
Poclight
Chemiluminescence Immunoassay Analyzer (CLIA C-5000)
The CLIA C-5000 is a high-performance, fully automated Chemiluminescence Immunoassay Analyzer designed to deliver precise, reliable, and rapid diagnostic results. Engineered with advanced chemiluminescence detection technology and integrated automation, the CLIA C-5000 is widely used in clinical laboratories, hospitals, and research facilities for immunological testing. Its robust design, high throughput, and user-friendly interface make it an essential tool for modern diagnostics.
Upgrade FIA to CLIA
SPECIFITATION
| Principle | Homogeneous Chemiluminescence Immunoassay |
|---|---|
| Time to first result | 3 min |
| Testing Capacities | 7 detection channels |
| Display Screen | 7inch LCD |
| Sample Type | Whole blood/Serum/Plasma |
| Precision | Whole blood Cv<5%< /td> |
| Throughput | 80T/h |
| Dimension | 325mm*231mm-213mm |
| Weight | <7kg< /td> |
ADVANTAGE
compact
A4-size footprint
Fats
3min
Maintenance-Free
600 days MTBF
Test capacities
7 detection channels
REAGENT
EASY ACCESS
Adding sample
Placing sample
Read the result
ASSAY PERFORMANCE
25 OH-VD
This assay is to be used as an aid in the assessment of vitamin D sufficiency.
Intended Use
Vitamin D is essential for bone health. In Children, severe deficiency leads to bone-malformation, known as rickets. Milder degrees of insufficiency are believed to cause reduced efficiency in the utilization of dietary calcium. Vitamin D deficiency causes muscle weakness; in elderly, the risk of falling has been attributed to the effect of vitamin D on muscle function.
HbA1c
This assay is intended for the quantitative determination of and % hemoglobin A1c (DCCT/NGSP) in whole blood.
Intended Use
HbA1c determinations are useful monitoring of long-term blood glucose control in individuals with diabetes mellitus. Moreover, this test is to be used as an aid in diagnosis of diabetes and identifying patients who may be at risk for developing diabetes.